Sysmex (SSMXY) Stock Price, News & Analysis

Company Overview

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis. In coagulation testing, Sysmex provides instruments and reagents to assess blood‐clotting function and monitor anticoagulant therapy. Its urine analyzers combine digital imaging with automated particle analysis, while immunochemistry systems enable quantitative measurement of biomarkers for infectious disease, hemostasis and diabetes monitoring.

Sysmex maintains a global footprint with regional headquarters and sales subsidiaries in North America, Europe, Asia‐Pacific, Latin America and Africa. Its products and services reach more than 150 countries, supported by local service networks that offer training, maintenance and technical support. The company collaborates with academic and industrial partners to develop molecular diagnostic assays and next‐generation testing platforms, positioning itself at the forefront of personalized medicine and digital health solutions.

Founded in 1968, Sysmex has grown through continuous investment in research and development. The company is led by President and Chief Executive Officer Yutaka Yamada, supported by an executive team focused on innovation, quality and international expansion. Over its history, Sysmex has earned a reputation for reliability and precision in clinical diagnostics, driving efforts to improve patient care and laboratory efficiency worldwide.

Key Stats

• Today's Range: $12.85 to $13.49
• 50-Day Range: $12.57 to $17.24
• 52-Week Range: $12.29 to $22.00
• Volume: 73,302 shs
• Average Volume: 186,238 shs
• Market Capitalization: $8.13 billion
• P/E Ratio: 25.82
• Dividend Yield: 1.24%
• Price Target: N/A
• Consensus Rating: Hold

SSMXY Stock Analysis - Frequently Asked Questions

How have SSMXY shares performed this year?

Sysmex's stock was trading at $18.28 at the beginning of the year. Since then, SSMXY stock has decreased by 29.4% and is now trading at $12.9120.

How were Sysmex's earnings last quarter?

Sysmex Corporation ADR (OTCMKTS:SSMXY) posted its earnings results on Wednesday, August, 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by $0.07. The firm had revenue of $717.09 million for the quarter, compared to analysts' expectations of $807.27 million. Sysmex had a net margin of 9.35% and a trailing twelve-month return on equity of 10.20%.

When did Sysmex's stock split?

Sysmex's stock split on Tuesday, April 2nd 2024.The 1.5-1 split was announced on Tuesday, April 2nd 2024. The newly issued shares were issued to shareholders after the market closes on Tuesday, April 2nd 2024. An investor that had 100 shares of stock prior to the split would have 150 shares after the split.

Does Sysmex have any subsidiaries?

Sysmex subsidiaries include these companies: HITADO GmbH, HYPHEN BioMed SAS, Jinan Sysmex Medical Electronics Co. Ltd., Medicaroid Corporation, PT.Sysmex Indonesia, RIKEN GENESIS CO. LTD., Sysmex America Inc., and others.

How do I buy shares of Sysmex?

Shares of SSMXY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/06/2025
• Today: 9/18/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:SSMXY
• CIK: 1517231
• Web: www.sysmex.co.jp
• Phone: (178) 265-0500
• Fax: 817-8265-0524
• Employees: 11,457
• Year Founded: 1968

Profitability

• EPS (Trailing Twelve Months): $0.50
• Trailing P/E Ratio: 25.82
• Forward P/E Ratio: 22.65
• P/E Growth: N/A
• Net Income: $357.79 million
• Net Margins: 9.35%
• Pretax Margin: 15.57%
• Return on Equity: 10.20%
• Return on Assets: 7.25%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 3.37
• Quick Ratio: 2.49

Sales & Book Value

• Annual Sales: $3.34 billion
• Price / Sales: 2.43
• Cash Flow: $0.98 per share
• Price / Cash Flow: 13.16
• Book Value: $4.92 per share
• Price / Book: 2.62

Miscellaneous

• Outstanding Shares: 629,480,000
• Free Float: N/A
• Market Cap: $8.13 billion
• Optionable: Not Optionable
• Beta: 1.10